Pancreatic Cancer Research

ResearcherColumbia UniversityNo recent work listed

Robert Lance Fine

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5011967890. Sources: ClinicalTrials.gov.

Their work

Papers
7 (first author 0, last author 3)
Trials
3 (principal investigator on 3)
Grants
0
Labs led
1
Collaborators
32
Papers, trials and grants by year

2003: 1 trial · 2004: 1 trial · 2005: 1 trial · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 3 papers · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: 1 paper

Papers 7

  1. Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer. Co-author DOI 10.18632/oncotarget.17237↗
  2. Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable p… Last author DOI 10.1002/cncr.29112↗
  3. Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer. Co-author DOI 10.1200/jco.2014.57.4244↗
  4. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with pre… Co-author DOI 10.1186/2051-1426-2-s3-p68↗
  5. The use of fluorescent probes in the study of reactive oxygen species in pancreatic cancer cells. Last author DOI 10.1007/978-1-62703-287-2_18↗
  6. Redirecting apoptosis to aponecrosis induces selective cytotoxicity to pancreatic cancer cells through increased ROS, decline in ATP levels, and VDAC. Last author DOI 10.1158/1535-7163.mct-13-0234↗
  7. Stereotactic radiosurgery plays a critical role in enhancing long-term survival in a patient with pancreatic cancer metastatic to the brain. Co-author PMID 24023326↗

Trials 3

  1. Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar Principal investigator NCT00869258↗
  2. Study of CellCept for Advanced Pancreatic Cancer Principal investigator NCT00997958↗
  3. Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) Principal investigator NCT00996333↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dung Thi Le · 3 shared papers, 2014–2017 · strength 0.13
  2. Elizabeth M. Jaffee · 3 shared papers, 2014–2017 · strength 0.13
  3. Daniel A. Laheru · 2 shared papers, 2015–2017 · strength 0.10
  4. Richard D. Dinnen · 2 shared papers, 2013 · strength 0.10
  5. Todd S. Crocenzi · 2 shared papers, 2014–2015 · strength 0.07
  6. Dirk G. Brockstedt · 2 shared papers, 2014–2015 · strength 0.07
  7. Herbert J. Zeh · 2 shared papers, 2014–2015 · strength 0.07
  8. Andrea Wang‐Gillam · 2 shared papers, 2014–2015 · strength 0.07
  9. Vincent J. Picozzi · 2 shared papers, 2014–2015 · strength 0.07
  10. Ana De Jesus‐Acosta · 1 shared paper, 2017 · strength 0.06
  11. Mark M. Yarchoan · 1 shared paper, 2017 · strength 0.06
  12. Ross C. Donehower · 1 shared paper, 2017 · strength 0.06
  13. Nilofer Saba Azad · 1 shared paper, 2017 · strength 0.06
  14. Michael Goggins · 1 shared paper, 2017 · strength 0.06
  15. Lei Zheng · 1 shared paper, 2017 · strength 0.06
  16. Paul E. Oberstein · 1 shared paper, 2017 · strength 0.06
  17. William H. Sherman · 1 shared paper, 2015 · strength 0.04
  18. Elizabeth M. Hecht · 1 shared paper, 2015 · strength 0.04
  19. Beth Schrope · 1 shared paper, 2015 · strength 0.04
  20. John A. Chabot · 1 shared paper, 2015 · strength 0.04
  21. John Allendorf · 1 shared paper, 2015 · strength 0.04
  22. Deirdre Jill Cohen · 1 shared paper, 2015 · strength 0.04
  23. Gregory M. Springett · 1 shared paper, 2015 · strength 0.04
  24. Jennifer N. Uram · 1 shared paper, 2015 · strength 0.04
  25. Tim F. Greten · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.